Recursion Pharmaceuticals Inc.
Clinical trials sponsored by Recursion Pharmaceuticals Inc., explained in plain language.
-
New pill tested for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new oral drug called REC-1245 for people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can help shrink tumors. Participants will take the pill daily for up to two years.
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for FAP patients: early trial targets dangerous polyps
Disease control Recruiting nowThis early-stage trial is testing an oral drug called REC-4881 in adults with Familial Adenomatous Polyposis (FAP), a genetic condition that causes many polyps and a high cancer risk. The study aims to see if the drug is safe, how it behaves in the body, and if it can reduce the …
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC